VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 21 of Oncotarget features Figure 6, "Kinome drug response overall and by subnetwork," from
Collins, et al.
Table of Contents
Research Papers: Immunology
|
| The glucocorticoid receptor in recipient cells keeps cytokine secretion in acute graftversushost disease at bay |
|
https://doi.org/10.18632/oncotarget.24602
|
| 15437-15450 |
Research Papers: Chromosome
|
| Replicationincompetent gammaretroviral and lentiviral vectorbased insertional mutagenesis screens identify prostate cancer progression genes |
|
https://doi.org/10.18632/oncotarget.24503
|
| 15451-15463 |
Research Papers
|
| Ajuba receptor mediates the internalization of tumorsecreted GRP78 into macrophages through different endocytosis pathways |
|
https://doi.org/10.18632/oncotarget.24090
|
| 15464-15479 |
|
| Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancer |
|
https://doi.org/10.18632/oncotarget.24337
|
| 15480-15497 |
|
| Combination therapy of chitosan gynostemma and motherwort alleviates the progression of experimental rat chronic renal failure by inhibiting STAT1 activation |
|
https://doi.org/10.18632/oncotarget.24125
|
| 15498-15511 |
|
| The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter |
|
https://doi.org/10.18632/oncotarget.24496
|
| 15512-15525 |
|
| Systematic characterization of autophagyrelated genes during the adipocyte differentiation using publicaccess data |
|
https://doi.org/10.18632/oncotarget.24506
|
| 15526-15541 |
|
| Serum levels of soluble CD163 and CXCL5 may be predictive markers for immunerelated adverse events in patients with advanced melanoma treated with nivolumab: a pilot study |
|
https://doi.org/10.18632/oncotarget.24509
|
| 15542-15551 |
|
| Description of organspecific phenotype and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver |
|
https://doi.org/10.18632/oncotarget.24514
|
| 15552-15565 |
|
| Relationship between the agonist activity of synthetic ligands of TRAILR2 and their cell surface binding modes |
|
https://doi.org/10.18632/oncotarget.24526
|
| 15566-15578 |
|
| Grape seed procyanidin extract against lung cancer: the role of microrna106b bioavailability and bioactivity |
|
https://doi.org/10.18632/oncotarget.24528
|
| 15579-15590 |
|
| Treatment of oral cancer using magnetized paclitaxel |
|
https://doi.org/10.18632/oncotarget.24570
|
| 15591-15605 |
|
| Selective lysis of breast carcinomas by simultaneous stimulation of sodium channels and blockade of sodium pumps |
|
https://doi.org/10.18632/oncotarget.24581
|
| 15606-15615 |
|
| New antimicrobial peptide kills drugresistant pathogens without detectable resistance |
|
https://doi.org/10.18632/oncotarget.24582
|
| 15616-15634 |
|
| Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosaminetreated mice |
|
https://doi.org/10.18632/oncotarget.24583
|
| 15635-15649 |
|
| Sympathoadrenergic activation by endurance exercise: Effect on metanephrines spillover and its role in predicting athlete’s performance |
|
https://doi.org/10.18632/oncotarget.24584
|
| 15650-15657 |
|
| CDK4/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer |
|
https://doi.org/10.18632/oncotarget.24585
|
| 15658-15672 |
|
| BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.24590
|
| 15673-15690 |
|
| Loss of neutrophil polarization in colon carcinoma liver metastases of mice with an inducible liverspecific IGFI deficiency |
|
https://doi.org/10.18632/oncotarget.24593
|
| 15691-15704 |
|
| Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas |
|
https://doi.org/10.18632/oncotarget.24594
|
| 15705-15720 |
|
| IL8 associates with a proangiogenic and mesenchymal subtype in glioblastoma |
|
https://doi.org/10.18632/oncotarget.24595
|
| 15721-15731 |
|
| Radiofrequency assisted pancreaticoduodenectomy for palliative surgical resection of locally advanced pancreatic adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.24596
|
| 15732-15739 |
|
| The long noncoding RNA <i>HOTAIR</i> is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma |
|
https://doi.org/10.18632/oncotarget.24597
|
| 15740-15756 |
|
| Impact of adjuvant hormonotherapy on radiationinduced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial |
|
https://doi.org/10.18632/oncotarget.24606
|
| 15757-15765 |
|
| Calciumsensing receptor CaSR promotes development of bone metastasis in renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.24607
|
| 15766-15779 |
|
| Pomalidomide enhanced gemcitabine and nabpaclitaxel on pancreatic cancer both <i>in vitro</i> and <i>in vivo</i> |
|
https://doi.org/10.18632/oncotarget.24608
|
| 15780-15791 |
Reviews
Corrections
|
| Correction: MicroRNA29a increased the intestinal membrane permeability of colonic epithelial cells in irritable bowel syndrome rats |
|
https://doi.org/10.18632/oncotarget.24848
|
| 15816-15816 |
|
| Correction: The outcomes and prognostic factors of acute respiratory failure in the patients 90 years old and over |
|
https://doi.org/10.18632/oncotarget.24864
|
| 15817-15817 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
